カルナバイオサイエンス(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4572/E00987Carna Biosciences,Inc.
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2025/02/07日証協無担保0株0%0株0%2,600株-68.67%
2025/02/07日証協有担保1,221,724株+121.48%3,300株-82.35%50,717株-37.78%
2025/01/31日証協無担保0株0%0株0%8,300株-75.73%
2025/01/31日証協有担保551,611株-44.4%18,700株-54.17%81,513株+85.67%
2025/01/24日証協無担保0株0%0株0%34,200株+80.95%
2025/01/24日証協有担保992,044株+8.48%40,800株+172%43,902株+39.82%
2025/01/17日証協無担保0株0%0株-100%18,900株+2.72%
2025/01/17日証協有担保914,529株-33.03%15,000株-66.82%31,400株+18.05%
2025/01/10日証協無担保0株0%100株0%18,400株+148.65%
2025/01/10日証協有担保1,365,595株+929.5%45,213株+1132.3%26,600株+129.31%
2024/12/30日証協無担保0株0%0株0%7,400株-96.6%
2024/12/30日証協有担保132,647株-80.85%3,669株-73.02%11,600株-98.17%
2024/12/27日証協無担保0株0%0株0%217,701株+1180.59%
2024/12/27日証協有担保692,848株-20.92%13,600株+1842.86%634,500株+5565.18%
2024/12/20日証協無担保0株-100%0株0%17,000株+12.58%
2024/12/20日証協有担保876,170株+2279.41%700株+133.33%11,200株+33.33%
2024/12/13日証協無担保800株+14.29%0株0%15,100株+160.34%
2024/12/13日証協有担保36,823株-89.16%300株-99.26%8,400株-68.18%
2024/12/06日証協無担保700株+75%0株0%5,800株+114.81%
2024/12/06日証協有担保339,580株+345.64%40,800株+81.33%26,400株-54.48%
2024/11/29日証協無担保400株+33.33%0株0%2,700株-92.86%
2024/11/29日証協有担保76,200株-95.31%22,500株-50.66%58,000株-29.1%
2024/11/22日証協無担保300株-70%0株0%37,810株+8.65%
2024/11/22日証協有担保1,623,516株+420.32%45,600株-73.16%81,800株+243.7%
2024/11/15日証協無担保1,000株-33.33%0株0%34,800株+376.06%
2024/11/15日証協有担保312,023株-43.13%169,900株+230.54%23,800株+41.67%
2024/11/08日証協無担保1,500株0%0株-100%7,310株+19.84%
2024/11/08日証協有担保548,638株+2405.2%51,400株+31.79%16,800株+330.77%
2024/11/01日証協無担保0株0%1,900株0%6,100株0%
2024/11/01日証協有担保21,900株-96.9%39,000株-47.37%3,900株-22%
2024/10/25日証協無担保0株0%0株0%6,100株-64.33%
2024/10/25日証協有担保707,402株+18.5%74,100株+338.46%5,000株-86.84%
2024/10/18日証協無担保0株0%0株0%17,100株+24.71%
2024/10/18日証協有担保596,963株-58.36%16,900株-84.73%38,000株+11.76%
2024/10/11日証協無担保0株0%0株0%13,712株+7.12%
2024/10/11日証協有担保1,433,487株+20.29%110,700株+228.49%34,000株-74.48%
2024/10/04日証協無担保0株0%0株0%12,800株-88.5%
2024/10/04日証協有担保1,191,723株+217.19%33,700株-72.2%133,211株-78.79%

※株式分割は考慮していませんのでご注意ください。

Page Top